THERAPROXEN- naproxen, .gamma.-aminobutyric acid kit Stati Uniti - inglese - NLM (National Library of Medicine)

theraproxen- naproxen, .gamma.-aminobutyric acid kit

physician therapeutics llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 250 mg - indications and usage carefully consider the potential benefits and risks of naproxen tablets, usp and other treatment options before deciding to use naproxen tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen as naproxen tablets, usp is indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea contraindications naproxen tablets, usp are contraindicated in patients with known hypersensitivity to naproxen. naproxen tablets, usp should not be

SENTRAVIL PM-25- amitriptyline hydrochloride, choline kit Stati Uniti - inglese - NLM (National Library of Medicine)

sentravil pm-25- amitriptyline hydrochloride, choline kit

physician therapeutics llc - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 25 mg - indications and usage for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. contraindications amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use durin

THERAFELDAMINE- piroxicam, .gamma.-aminobutyric acid kit Stati Uniti - inglese - NLM (National Library of Medicine)

therafeldamine- piroxicam, .gamma.-aminobutyric acid kit

physician therapeutics llc - piroxicam (unii: 13t4o6vmam) (piroxicam - unii:13t4o6vmam) - piroxicam 20 mg - indications and usage carefully consider the potential benefits and risks of piroxicam and other treatment options before deciding to use piroxicam. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). piroxicam is indicated: • for relief of the signs and symptoms of osteoarthritis. • for relief of the signs and symptoms of rheumatoid arthritis. contraindications piroxicam is contraindicated in patients with known hypersensitivity to piroxicam. piroxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings: anaphylactoid reactions and precautions: preexisting asthma). piroxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings). pediatric use safety and effect

THERAPROXEN-500- naproxen, .gamma.-aminobutyric acid kit Stati Uniti - inglese - NLM (National Library of Medicine)

theraproxen-500- naproxen, .gamma.-aminobutyric acid kit

physician therapeutics llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 500 mg - indications and usage carefully consider the potential benefits and risks of naproxen, naproxen sodium and other treatment options before deciding to use naproxen and naproxen sodium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen as naproxen or naproxen sodium tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. naproxen as naproxen and naproxen sodium tablets are also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms

APPBUTAMONE-D- bupropion hydrochloride, tyrosine kit Stati Uniti - inglese - NLM (National Library of Medicine)

appbutamone-d- bupropion hydrochloride, tyrosine kit

physician therapeutics llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 75 mg - indications and usage bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder. a physician considering bupropion hydrochloride tablets for the management of a patient’s first episode of depression should be aware that the drug may cause generalized seizures in a dose-dependent manner with an approximate incidence of 0.4% (4/1,000). this incidence of seizures may exceed that of other marketed antidepressants by as much as 4-fold. this relative risk is only an approximate estimate because no direct comparative studies have been conducted (see warnings). the efficacy of bupropion hydrochloride tablets has been established in 3 placebo-controlled trials, including 2 of approximately 3 weeks’ duration in depressed inpatients and one of approximately 6 weeks’ duration in depressed outpatients. the depressive disorder of the patients studied corresponds most closely to the major depression category of the apa diagnostic and statistical manual iii. major depression implies a promi

VICOPROFEN- hydrocodone bitartrate and ibuprofen tablet, coated Stati Uniti - inglese - NLM (National Library of Medicine)

vicoprofen- hydrocodone bitartrate and ibuprofen tablet, coated

physicians total care, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - hydrocodone bitartrate 7.5 mg - carefully consider the potential benefits and risks of vicoprofen and other treatment options before deciding to use vicoprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). vicoprofen tablets are indicated for the short-term (generally less than 10 days) management of acute pain. vicoprofen is not indicated for the treatment of such conditions as osteoarthritis or rheumatoid arthritis. vicoprofen is contraindicated in patients with known hypersensitivity to hydrocodone or ibuprofen. patients known to be hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone. vicoprofen should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings – anaphylactoid reactions , and precautions - preexisting asthma ). vicoprofen is contraindicate

NAPRELAN- naproxen sodium tablet, film coated, extended release Stati Uniti - inglese - NLM (National Library of Medicine)

naprelan- naproxen sodium tablet, film coated, extended release

physicians total care, inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor

FLECTOR- diclofenac epolamine patch Stati Uniti - inglese - NLM (National Library of Medicine)

flector- diclofenac epolamine patch

physicians total care, inc. - diclofenac epolamine (unii: x5f8ekl9zg) (diclofenac - unii:144o8ql0l1) - diclofenac epolamine 180 mg - carefully consider the potential benefits and risks of flector® patch and other treatment options before deciding to use flector® patch. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (seewarnings ). flector® patch is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions. flector® patch is contraindicated in patients with known hypersensitivity to diclofenac. flector® patch should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (seewarnings - anaphylactoid reactions , andprecautions - preexisting asthma ). flector® patch is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (seewarnings ). flector® patch should not be applied to non-intact or damaged skin r

OSMOPREP- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet Stati Uniti - inglese - NLM (National Library of Medicine)

osmoprep- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet

physicians total care, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic anhydrous (unii: 22ado53m6f) (sodium cation - unii:lyr4m0nh37) - sodium cation 1.102 g - osmoprep tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. osmoprep tablets are contraindicated in patients with biopsy-proven acute phosphate nephropathy. osmoprep tablets are contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients. laxatives and purgatives (including osmoprep) have the potential for abuse by bulimia nervosa patients who frequently have binge eating and vomiting.

TESTIM- testosterone gel Stati Uniti - inglese - NLM (National Library of Medicine)

testim- testosterone gel

physicians total care, inc. - testosterone (unii: 3xmk78s47o) (testosterone - unii:3xmk78s47o) - testosterone 50 mg in 5 g - testim® is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: - primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. these men usually have low serum testosterone levels and gonadotropins (fsh, lh) above the normal range. - hypogonadotropic hypogonadism (congenital or acquired): idiopathic gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. these men have low testosterone serum levels but have gonadotropins in the normal or low range. testim® has not been clinically evaluated in males under 18 years of age. androgens are contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate. testim® is not indica